Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6M1A3

Entry ID Method Resolution Chain Position Source
AF-Q6M1A3-F1 Predicted AlphaFoldDB

No variants for Q6M1A3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6M1A3

No associated diseases with Q6M1A3

3 regional properties for Q6M1A3

Type Name Position InterPro Accession
domain Translation elongation factor EFTs/EF1B, dimerisation 71 - 275 IPR014039
conserved_site Translation elongation factor Ts, conserved site 12 - 27 IPR018101-1
conserved_site Translation elongation factor Ts, conserved site 75 - 85 IPR018101-2

Functions

Description
EC Number 5.4.99.27 Transferring other groups
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
RNA binding Binding to an RNA molecule or a portion thereof.
tRNA pseudouridine synthase activity Catalysis of the reaction: tRNA uridine = tRNA pseudouridine. Conversion of uridine in a tRNA molecule to pseudouridine by rotation of the C1'-N-1 glycosidic bond of uridine in RNA to a C1'-C5.

2 GO annotations of biological process

Name Definition
pseudouridine synthesis The intramolecular conversion of uridine to pseudouridine within an RNA molecule. This posttranscriptional base modification occurs in tRNA, rRNA, and snRNAs.
tRNA processing The process in which a pre-tRNA molecule is converted to a mature tRNA, ready for addition of an aminoacyl group.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MKFRQKHEDF IVNEILEYEL NDYGNYFLYK LQKNGIENLK AISYLSKNFE VPTKEIGYCG
70 80 90 100 110 120
LKDRHAITTQ YVSIPKEYGK LSLDEDNLKL EYVGTIEKPL KIGRLYGNRF EIIARAVDKD
130 140 150 160 170 180
EFLKIADNIR NLSSGAPNYY DDQRFGSVFN GKFIAKEILK GNYEEVVKIL LTSYTKSEKK
190 200 210 220 230 240
QLKDLKRFIA KNWGNWDECL EYIDKKQIRS KMFRNMVKSL TYENDFKKAF KYVDNRLKEL
250 260 270 280 290 300
FISAYQSYLW NECLKEFLKE VIPKENRIYV DYSCGTFLFY ENIEEELFDK LKEMDFPTIV
310 320 330 340 350 360
SDVEYTDPEK RIIKAILKKE RIKISDFEKL DFGKLKYTKR PIISIPEDVN TGKFKSDELN
370 380
SKKYKIDLEF SLKKGSYATI ILKRVFNIL